our credo

 

Amato Pharmaceutical Products, Ltd. thinks first and foremost of the life and health of patients, and along with its products, delivers appropriate information on medical conditions and pharmaceuticals. By conducting advanced research and developing the design and manufacturing of its products, Amato creates new value for patients and for those desiring good health, while also offering them “Peace of Mind, and Sense of Excitement.”

「安らぎと感動」

Amato originally began its activities about 200 years ago, with its predecessor company engaging in the sale of traditional drugs. In the early days, Amato’s predecessor responded to the needs of pilgrims coming to worship in shrines. As a pharmaceutical manufacturing enterprise, Amato has answered the need of patients for relief from pain, suffering, and anxiety. These many years of service to patients have enabled Amato to develop medicines with its customers and patients in mind.

In 1813, our predecessor opened a traditional drug seller shop located in front of a shrine in the northern part of Kyoto, Japan, calling it “Amazuya” from his name “Amazuya Tosuke”. This drugstore formulated traditional medicines and provided information on treatment and preventive methods to pilgrims coming to the shrine to pray for the safety of their homes and cures for diseases.

Side Story 1

“Amato Preparation for Warming Your Stomach” is one example of Amazuya drugstore’s products. It was designed to support patients with the message, “This will help you overcome this illness.” Because of its packaging, the concept was convincing and it was well designed for patients to take.

Subsequently, Amazuya Tosuke VIII, Kinzo Ohtsuki, created pharmaceuticals for the treatment of hemorrhoids for use in Kyoto University Hospital. The efficacy of their preparations was highly acclaimed, and they were further developed as medicinal treatments. In 1921, the Amato Pharmaceutical Research Institute was founded, and at the same time BORRAGINOL® was created as a treatment for hemorrhoids.

Side Story 2

BORRAGINOL® was the first preparation for hemorrhoids to receive approval with clinical data. When it was approved, hemorrhoids were not generally recognized as a disease, so Amato first started educating the public that the pains patients experience were, in fact, hemorrhoids, and it is a treatable medical condition.

Since its development, BORRAGINOL® has undergone improvement with the aim of creating more effective and safer medication. Moreover, to better respond to patient needs, Amato has perfected the design of BORRAGINOL®, including improvements in labeling and shape, as well as making it easier to carry for patients.

Side Story 3

Since its development, BORRAGINOL® has undergone improvement with the aim of creating more effective and safer medication. Moreover, to better respond to patient needs, Amato has perfected the design of BORRAGINOL®, including improvements in labeling and shape, as well as making it easier to carry for patients.

In recent times as well, Amato has taken initiatives to respond promptly to changes in standards and good manufacturing practices (GMP) related to the safety and quality of pharmaceuticals and was the first to introduce a fully automated production line for the forming and packaging of suppositories.

Amato has also continued to respond to GxP, including good quality practices (GQP) and good clinical practices (GCP). Also in its Sanda Plant, Amato has led the way in adopting processes that respond fully to PIC/S, automated production lines designed for long operating periods, and other innovations.

The initiatives Amato will take in its next 100 years will be an extension of what we have found and what we have believed over the 200 years since Amato’s establishment. Amato will continue to think first and foremost of the life and health of patients and will work to create new value for those desiring to have good health in life.